|1.||Carrier, Lucie: 17 articles (06/2015 - 08/2004)|
|2.||Cunningham, Madeleine W: 13 articles (05/2014 - 01/2002)|
|3.||Sadayappan, Sakthivel: 11 articles (11/2015 - 02/2009)|
|4.||Seidman, J G: 11 articles (07/2014 - 04/2000)|
|5.||Kodama, Makoto: 11 articles (07/2012 - 04/2002)|
|6.||Schlossarek, Saskia: 10 articles (06/2015 - 08/2007)|
|7.||Massilamany, Chandirasegaran: 9 articles (01/2016 - 01/2011)|
|8.||Reddy, Jay: 9 articles (01/2016 - 01/2011)|
|9.||Gangaplara, Arunakumar: 9 articles (01/2016 - 01/2011)|
|10.||Watanabe, Kenichi: 9 articles (12/2013 - 01/2003)|
07/01/2009 - "Oral tolerization with cardiac myosin peptide (614-629) ameliorates experimental autoimmune myocarditis: role of STAT 6 genes in BALB/CJ mice."
01/01/2014 - "This study involved experimental autoimmune myocarditis (EAM) induced with cardiac myosin heavy chain (Myhc)-α 334-352 in A/J mice; the affected animals develop lymphocytic myocarditis but with no apparent clinical signs. "
12/01/2013 - "In this study, we used a rat model of cardiac myosin-induced experimental autoimmune myocarditis to test the effects of ML diet (MLD) (5%) on various markers of cardiac remodeling and function. "
01/01/2012 - "No direct role for signaling through TLR2 had been shown in myocarditis although published studies show that cardiac myosin is an endogenous TLR2 ligand and stimulates pro-inflammatory cytokine expression by dendritic cells in vitro. "
05/01/2006 - "This study was aimed at evaluating whether anti-CD4 monoclonal antibody could induce immune tolerance to porcine cardiac myosin and whether the immune tolerance could protect rats with autoimmune myocarditis from myocardial injury. "
12/01/2009 - "These studies suggest that cardiac myosin activators offer the promise of a safe and effective treatment for heart failure. "
11/01/2011 - "Heart failure: Cardiac myosin activator shows promise in phase II trial."
10/01/2007 - "The cardiac myosin isoform shifts in this study were similar to those observed in end-stage human heart failure and more severe than those reported in less prolonged pacing models, supporting the use of this model for further study of end-stage human heart failure. "
11/01/2006 - "Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF."
07/01/2013 - "Cardiac myosin is a potential molecular target for heart failure imaging since its changes can be used to assess the function of heart. "
|3.||Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
08/01/2001 - "Over 40 different mutations in the cardiac myosin heavy chain gene (MYH7) have been associated with familial hypertrophic cardiomyopathy (FHC), but no study has analyzed variation at this locus within the normal human population. "
04/01/2013 - "Familial Hypertrophic Cardiomyopathy (FHC) is frequently caused by mutations in the β-cardiac myosin heavy chain (β-MyHC). "
06/20/2012 - "Mice heterozygous for this mutation in the α-cardiac myosin isoform display typical familial hypertrophic cardiomyopathy pathology. "
06/20/2012 - "Cell-intrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy."
08/01/2007 - "A p.R870H mutation in the beta-cardiac myosin heavy chain 7 gene causes familial hypertrophic cardiomyopathy in several members of an Indian family."
01/01/2000 - "To study whether there was an anti-cardiac myosin antibody (AMA) in serum of patients with myocardial infarction (AMI), relationship between AMA and the prognosis in patients with AMI was investigated. "
09/01/1987 - "The purpose of our study was to evaluate the effectiveness of a fibrinolytic treatment administered in the acute phase of myocardial infarction by measuring in the plasma, the circulating fragments of human cardiac myosin. "
02/08/2006 - "Cellular autoimmunity to cardiac myosin in patients with a recent myocardial infarction."
06/01/2005 - "BiELSIA detected cardiac myosin heavy chain fragments in sera of patients obtained at the time of emergency department admission for acute myocardial infarction, but not in normal sera. "
06/01/2001 - "Myocardial infarction (MI) can be monitored using several protein markers including human cardiac myosin (HCM). "
04/01/1991 - "To study the transcriptional regulatory mechanisms which mediate cardiac-specific and inducible expression during myocardial cell hypertrophy, we have extensively characterized the rat cardiac myosin light-chain-2 (MLC-2) gene as a model system. "
12/15/2013 - "Increase in cardiac myosin heavy-chain (MyHC) alpha protein isoform in hibernating ground squirrels, with echocardiographic visualization of ventricular wall hypertrophy and prolonged contraction."
02/01/2001 - "Treatment also produced cardiomyocyte hypertrophy and a 5.4-fold increase in alpha-cardiac myosin content. "
05/01/1993 - "beta-cardiac myosin heavy chain (beta-MHC) isoform is predominantly expressed while alpha-MHC is suppressed in pressure overload hypertrophy. "
04/01/1993 - "beta-cardiac myosin heavy chain (beta-MHC) isoform was predominantly expressed and alpha-MHC was suppressed in pressure overload hypertrophy. "
|1.||Protein Isoforms (Isoforms)
|5.||Adenosine Triphosphate (ATP)
|8.||Carrier Proteins (Binding Protein)
|3.||Transplantation (Transplant Recipients)